Skip to search formSkip to main contentSkip to account menu

Vaccinia Vaccine

A class of antineoplastic vaccines containing the vaccinia virus, originally used for immunization against smallpox, as a viral vector and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
BACKGROUND Many countries have stockpiled vaccines because of concerns about the reemergence of smallpox. Traditional smallpox… 
Review
2017
Review
2017
Possible role of nanocarriers in drug delivery against cervical cancer
ABSTRACT Introduction: Cervical cancer is the second most common cancer and the largest cancer killer among women in most… 
Highly Cited
2015
Highly Cited
2015
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell–Mediated Tumor Control in the Genital Tract
Purpose: Two viral oncoproteins, E6 and E7, are expressed in all human papillomavirus (HPV)–infected cells, from initial… 
Highly Cited
2008
Highly Cited
2008
Development of a Listeria monocytogenes based vaccine against prostate cancer
Prostate specific antigen (PSA) is a likely immunotherapeutic target antigen for prostate cancer, the second leading cause of… 
Highly Cited
2003
Highly Cited
2003
Improved Assay To Detect Neutralizing Antibody following Vaccination with Diluted or Undiluted Vaccinia (Dryvax) Vaccine
ABSTRACT The assessment of immunogenicity of a diluted vaccinia vaccine for possible widespread use of a diluted vaccine in the… 
Highly Cited
1997
Highly Cited
1997
Immunologic responses to vaccinia vaccines administered by different parenteral routes.
To develop a less reactogenic but equally immunogenic vaccine, this study of 91 human volunteers compared the safety and… 
Highly Cited
1996
Highly Cited
1996
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.
Presentation of antigenic peptides by MHC class II molecules to CD4+ T cells is critical to the generation of antitumor immunity… 
Highly Cited
1996
Highly Cited
1996
Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
Interleukin-2 (IL-2) has been an effective immune modulator in several active-specific immunotherapy experimental protocols using… 
Highly Cited
1992
Highly Cited
1992
Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
BACKGROUND Human carcinoembryonic antigen (CEA) is a 180-kd glycoprotein expressed in human colorectal, gastric, pancreatic… 
1972
1972
Lymphocyte-macrophage interaction in antigen induced in vitro lymphocyte transformation in patients with the Wiskott-Aldrich syndrome and other diseases with anergy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License